WAKING UP TO SLEEPINESS: MODAFINIL, THE MEDIA AND THE PHARMACEUTICALISATION OF EVERYDAY/NIGHT LIFE Introduction
Recent years have witnessed an upsurge of sociological interest in pharmaceuticals, including on-going research on the regulation of the pharmaceutical industry (Abraham 1995, Abraham and Lewis 2002) ; related debates on globalisation and the pharmaceutical industry (Busfield 2003) ; the role of the pharmaceutical industry in 'disease mongering' (Blech 2006 ) and the medicalisation of society (Conrad 2007) ; the meaning and use of medications in lay culture and everyday life (Britten 1996, Gabe and Lipshitz-Phillips 1982) , and; studies of pharmacies, pharmacists, prescribing and concordance (Britten et al 2004 , Stevenson et al 2002 , Harding and Taylor 1997 .
(i) Pharmaceuticals and the media
Another key issue here concerns the role and function of the media in relation pharmaceuticals and the pharmaceuticalisation of everyday life.
Media coverage of pharmaceuticals, as previous studies have shown, is complex and variable over time. Often, when drugs are first discovered or licensed, media coverage tends to be positive in tone and content, including enthusiastic headlines extolling the virtues of a new 'breakthrough' or 'wonder drug'. Nelkin (1995) , for example, highlights the wave of enthusiastic media attention which Prozac (dubbed the 'feel good drug') received in the 1990s, with Viagra subsequently following in its footsteps. If or when unwelcome side effects become apparent, however, or misuse of some sort on the part of doctors or the lay populace is detected, then negative constructions or demonisation of the drug in question seems to predominate or prevail. We see this very
clearly, for example, with regard to media coverage of benzodiazepines over time. Gabe and Bury (1996) , for instance, note the considerable media attention devoted to the risks of taking benzodiazepines over the last 40 years. When first prescribed to patients in the 1960s, the media gave these drugs a 'generally enthusiastic welcome ' (1996: 76) . As this new generation of tranquillizers became more popular, however, their therapeutic value ceased to be 'newsworthy', with more critical coverage developing from the 1970s onwards --coverage highlighting both the risks of the drugs 'addictive potential' and journalistic imperatives for 'dramatisation ' and 'personalisation' (1996: 78 . See also Cohen 1983) .
Media treatment of medicines and drugs then, as Seale comments, 'demonstrates a tendency to idealise or stigmatise, creating oppositional extremes ' (2002: 152: See also Entwistle and Sheldon 1999). Rarely do the media present a 'balanced picture of harm and benefit contained in a single substance ' (2002: 148) . Whilst the actions of drug companies, indeed, are often subject to criticism, the media are frequently accused of promoting rather than challenging pharmaceutical interests, wittingly or unwittingly: a point which returns us notions of 'disease mongering' mentioned above (see, for example, Blech 2006 and Moynihan et al. 2002) . Whilst 'new' media such the Internet, moreover, may provide spaces or forums to challenge or resist these processes, they may equally provide new avenues or channels for the medicalisation or pharmaceuticalisation of daily life (see, for example, Fox et al. 2005) .
(ii) Modafinil: The shape of things to come?
It is against this backdrop of recent sociological work on pharmaceuticals in general and the role of the media in relation to pharmaceuticals in particular, that this paper is located. coverage we were most interested in, for the purposes of this particular paper at least, articles were selected from inclusion in the study if any of these search terms were mentioned three or more times. This resulted in a total of 54 articles across all papers sampled, with a higher proportion of articles in the more 'serious papers' -a finding which held across all search criteria deployed.
A variety of different techniques are now available for the analysis of media materials in general and newspapers in particular, including more quantitative forms of analysis such as content analysis and more qualitative forms of analysis such as discourse analysis (Fenton et al. 1998 , Potter 1996 . Our own approach favoured a more qualitative approach. Articles were read, catalogued and compared in terms of key words and phrases, key developing issues and storylines, the use of 'experts' and/or research data, evidence of medicalisation/disease mongering, how the reader was addressed/drawn into the piece, and the vocabulary used, particularly the 'moral' messages, rhetorical styles and/or 'emotional' overtones of these selected articles. Emerging debates and discourses were then used as an aid to further qualitative, interpretive analysis on how such articles constructed their subject matter and how they were intended to be read.
Discourses and Debates: Medicalisation and beyond
Four main themes emerged in our sample, which pertain respectively to Table 2 . Similarly, the majority of press coverage of sporting competition across all newspapers pertained to an event that materialised in 2003 and rumbled on into 2004 -see Table 2 .
As Kerry James, (a college lecturer), who became so bad that she 'frequently fell asleep during meetings, over meals and once even had to find an empty teaching room in which to take a nap on the floor'. Kerry, the reader is told, was eventually diagnosed with narcolepsy and since then she has been taking Provigil, which means she 'can now go virtually through the day without needing to nap'.
Gradually however, over time, these narcolepsy based storylines are The article, however, in a variant on the theme of medical expertise, concludes with a quote from a representative of the ADHD information service, Andrea Bilbow, who states that: 'the "stay awake" pill had already been tested on adults with ADHD and seemed to work well…If it proves to have few side-effects, then it is obviously going to be a useful (
ii) Lifestyle choices: flexible workers and party people;
Another key concern articulated and conveyed in this press coverage of Modafinil, pertains to the potential of the drug to blur the boundaries between the aforementioned 'legitimate' treatment of medical conditions and its uses and abuses as a (lifestyle) drug of choice.
Again we see this articulated in the press in a variety of ways. The Daily American users, the reader is told, 'describe in enthusiastic terms how the pill has enabled them to stay awake without the jitteriness and anxiety brought about by large doses of caffeine'. As such, it is claimed, the drug could 'undergo the "Viagra phenomenon", in which its main use would be to enhance lifestyles rather than treat medical conditions' (our emphasis). Drawing an analogy with food, are we indulging in a form of 'somorexia', a deluded and unhealthy belief that we can do without sleep…Or is the whole notion that our 24/7 lifestyle is creating a nationwide sleep-debt itself a delusion?
The problem however, the article concedes, in somewhat pessimistic tones, is that: and self-prescribing medicines which they hope will improve their looks, job performance or prowess in the bedroom rather than treat a specific condition or disease' (our emphases). There is even, the article warns, a 'darker side to the "lifestyle drugs" industry', in which 'many drugs sold online are fakes that at best will not have the effect and at worst could kill'. Provigil is then drawn into the picture, alongside other drugs such as Prozac, Ritalin, Viagra and the statin Lipitor, noting how strict regulations on prescribing Provigil were eased two years ago, and how 'clubbers are using it to keep partying through the night, while businessmen are buying it to help them through long days in the office, and students are taking it to keep revising'. Doctors, it adds, have 'warned that the drug can be psychologically addictive and can induce headaches and nausea'.
Not all articles, however, appeared to share these concerns, or at the very least seemed happy to endorse more widespread usage of the drug beyond But 'most importantly', the article goes on to state, echoing the aforementioned theme of accident reduction or prevention:
…lives would be saved on the roads, especially motorways, if long-distance drivers, whether in giant trucks or Minis, not only had regular rests but took the occasional Provigil tablet when there was any danger of them dropping off.
Modafinil then, as this press coverage suggests, is indeed construed and constructed as a somewhat 'controversial' drug, precisely because of its appeal to a wide range of potential users and abusers in the name of work or play, productivity or pleasure. There is, however, another potential market for the drug that looms large in this press coverage, one that takes us far beyond the realms of civil society.
(iii) Military operations: sleep as a 'commodity' of war;
Military uses or deployments of Provigil also featured in our newspaper sample, particularly in the more 'serious' papers. As with medical uses of the drug, some of this coverage adopted a rather matter-of-fact style of 'I was offered a lot of things and asked to test them to see if I responded better to certain products', she said. 'I was like a guinea pig. I tried a lot of stimulants and Modafinil suited me perfectly.
The same for tetrahydrogestrinone (THG), which helped put on muscle very quickly'.
As for White's claim to be suffering from narcolepsy, this, the reader is informed, was simply a 'cover story': '"I never suffered from narcolepsy", White said. "I never even knew the word existed until a few hours after the announcement of my positive test"'.
Whilst White is singled out for sustained press attention here, coverage also extended to reports of other athletes implicated in this controversy. Modafinil, then, may very well be regarded as the latest in a long list of drugs and substances banned for use in sport, raising once again the spectre of unfair advantage. It is nonetheless, as White's particular story clearly attests, instructive on a number of further counts, not least in terms of: (i) bogus appeals to medical conditions as (il)legimate grounds for using this drug; (ii) the ensuing IAAF, WADA and USADA deliberations as to whether or not Modafinil was in fact a 'banned substance', and perhaps most importantly of all; (iii) the role of the pharmaceutical industry itself in this critical test case. In reporting on these issues, therefore, the press again provide an effective vehicle for the articulation of a broader series of moral concerns and agendas regarding the potential uses and abuses of this drug in the competition or race to get ahead.
Discussion and concluding remarks
This study has been primarily concerned with discourses and debates on Provigil/Modafinil in the British national press. Further work, as such, is clearly needed not simply in terms of the social construction of this drug in other types of media, both new and old, but in relation to questions of audience reception/response as well as the specific cultures and institutional arrangements involved in the production of newsworthy stories in this domain. Our data nonetheless, returning to the questions posed at the beginning of this paper, are instructive on a number of counts and at a number of different levels.
In terms of the content of newspaper coverage, constructions of Modafinil in the press, as we have seen, cluster around four key themes pertaining to the medical, lifestyle, military and sporting uses and abuses of the drug --with greatest coverage accorded to the latter theme (see Table 1 ), due to a particular scandal emerging in 2003 concerning the use of the drug (see Table 2 ). Whilst medical uses of Provigil, in this respect, capitalism where achievement is prized, alertness is emphasized and vigilance is valorised. Modafinil, indeed, is simply the first of a new wave of drugs, including CX717 currently in trial, that provide the pharmacological means to prolong, promote and police our wakefulness, fuelling claims (rightly or wrongly) that sooner or later we will be able to pharmacologically or genetically 'switch' or 'turn sleep off' altogether (Lawton 2006: 34) .
These issues in turn raise related questions of 'pharmacological Calvinism' (Conrad 2007 , Klerman 1972 : the Puritan, disciplined, ascetic belief, that is to say, that we need to work hard in order to achieve a valued goal or objective rather than take drugs or medications as a short-cut to success. To the extent that drugs such as Modafinil embody developments that carry profound implications for who we are and who we want to be.
In reporting on these developments and rehearsing these dilemmas, discourses and debates, the press, in effect, are not simply alerting us to 4. Thanks to one of the anonymous referees for drawing this point to our attention.
5. Thanks to one of the anonymous referees for highlighting this source.
6. At the time of writing, the Times Higher Education Supplement has just published a full page feature on the use of Provigil and other socalled 'smart drugs' in academia: a growing trend in the global academic community, it is suggested, in a time squeezed, performance pressured, results-driven culture such as ours (Tysome 2007 ; see also Bee 2007 and Martin 2007 ). This in turn suggests that press concerns over the uses and abuses of Modafinil in relation to wakefulness are now being joined by, if not eclipsed by, concerns over its cognitive/brain-boosting qualities as a 'smart drug', particularly in educational contexts but also more widely in society at large. 
